Highlights
NASDAQ: CFRX       Contrafect
Last Price Today's Change   Day's Range   Trading Volume
5.90   -0.44 (6.94%)  5.64 - 7.06  549,400

Overview

 
Avg Volume (4 weeks):539,775
4 Weeks Range:5.25 - 8.00
4 Weeks Price Volatility (%):
23.64%
52 Weeks Range:0.269 - 12.10
52 Weeks Price Volatility (%):
47.60%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

ContraFect Corp is a US-based clinical-stage biotechnology company which focuses on discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases including those caused by drug-resistant pathogens, particularly treated in hospital settings. The company has developed advanced lysin product candidate, CF-301 for the treatment of Staph aureus bacteremia, including endocarditis. It also emphasizes on addressing drug-resistant infections using product candidates from its lysin and monoclonal antibody platforms that target conserved regions of either bacteria or viruses. The company operates through the single segment being Developing therapeutic protein and antibody products.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5841  2426  488  170 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 RIGL 4.125+1.965 
 SQQQ 6.42-0.14 
 NIO 14.09+0.25 
 LK 1.38+1.38 
 VXRT 16.97+4.85 
 WFC 24.25-1.16 
 BOXL 1.94+0.37 
 F 6.36+0.30 
 XLF 23.68+0.12 
 SPY 318.92+4.08 
Partners & Brokers